ITeos Therapeutics Stock (NASDAQ: ITOS) stock price, news, charts, stock research, profile.
You can purchase shares of ITeos Therapeutics (NASDAQ:ITOS) through any online brokerage.
Other companies in ITeos Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Inozyme Pharma (NASDAQ:INZY), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
ITeos Therapeutics has a consensus price target of $37.00.
The stock price for ITeos Therapeutics (NASDAQ: ITOS) is $10.13 last updated September 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for ITeos Therapeutics.
ITeos Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for ITeos Therapeutics.
ITeos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.